Adamis Pharmaceuticals
  • Home
  • Investors
  • Newsroom
  • Careers
  • Leadership
  • Contact Us
  • About Us
  • Adamis Labs
  • Adamis Therapeutics
  • Science
  • Pipeline
Tweet   
    • Subscribe to News/Alerts

    LATEST NEWS
    more news

    Thursday, Nov 3, 2011

    • Adamis Prostate Cancer Drug APC-100 Receives Allowance for Patent in CanadaBusiness Wire

    Tuesday, Oct 25, 2011

    • Crystal Research Report on Adamis Pharmaceuticals

    Tuesday, Oct 4, 2011
    • ADAMIS PHARMACEUTICALS CORP Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online

    Thursday, Sep 22, 2011
    • Adamis Prostate Cancer Drug APC-200 Granted Patents in Singapore and South AfricaBusiness Wire

    Friday, Sep 16, 2011
    • ADAMIS PHARMACEUTICALS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or PrEDGAR Online

    Tuesday, Aug 30, 2011

    • Adamis Pharmaceuticals Begins Prostate Cancer TrialBusiness Wire

    Monday, Aug 15, 2011

    • ADAMIS PHARMACEUTICALS CORP FinancialsEDGAR Online Financialspan>

    Thursday, Jul 28, 2011

    • ADAMIS PHARMACEUTICALS CORP Files SEC form 8-K, Other EventsEDGAR Online

    Thursday, Jul 21, 2011

    • Adamis Prostate Cancer Drug APC-100 Granted a Patent in USBusiness Wire

    Wednesday, Jul 20, 2011

    • Adamis Reports APC-300 Kills Human Prostate Cancer CellsBusiness Wire

    Wednesday, Jul 13, 2011

    • Adamis Vaccine Technology Granted a Patent in EuropeBusiness Wire
  • Welcome to Adamis Pharmaceuticals

    Adamis Pharmaceuticals is a commercial-stage specialty pharmaceutical company with products concentrated in three major areas: Allergy/Respiratory, Oncology and Immunology/Infectious Diseases.


    NEW YORK, NY (October 26, 2011)...Crystal Research Associates, LLC
    announced today that it has issued an Executive Informational Overview® (EIO®)
    on Adamis Pharmaceuticals Corp. (ADMP-OTCBB).
    The full 52-page report by Jeffrey J. Kraws can be seen here



    Adamis Pharmaceuticals Product Pipeline

  • Copyright © 2012 Adamis Pharmaceuticals Corporation, All rights reserved.
  •   
  •   
  •       
  •   
  •   
  •   
  •   
  • Terms of Use/Privacy Policy